Company intelligence / Profile preview
Sun Pharma Advanced Research
Mumbai, Maharashtra, Indiasparc.life ↗
- Ownership
- Private
- Employees
- ~409
- Development stage
- Other
01
Overview
SPARC has a pipeline focused on oncology and immunology. Its lead asset vodobatinib targets BCR-ABL for refractory CML and has advanced to Phase 2. The company also develops an anti-MUC1 ADC for multiple cancers (preclinical) and a selective S1PR1 agonist for autoimmune disorders like psoriasis and atopic dermatitis. Some programs have been licensed out or discontinued due to strategic reasons but the company maintains a robust pipeline with several assets advancing through clinical development[7][8].
- Therapeutic areas
- DermatologyOncology
- Modalities
- Small moleculeAntibody-drug conjugateTopical agent
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Sun Pharmaceutical Industries Ltd. (licensing of vibozilimod/SCD‑044)Tiller TherapeuticsVisiox Pharma
Beyond the preview
Go deeper on Sun Pharma Advanced Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sun Pharma Advanced Research.